You are here

Article info

Article menu

Download PDFPDF

Oral Presentations
SATURDAY, 15 JUNE 2019
Osteoarthritis: Research in motion
Late breaking abstract session
LB0007 SUBCUTANEOUS TANEZUMAB FOR OSTEOARTHRITIS PAIN: A 24-WEEK PHASE 3 STUDY WITH A 24-WEEK FOLLOW UP
Free

Authors

Citation

Berenbaum F, Blanco FJ, Guermazi A, et al
LB0007 SUBCUTANEOUS TANEZUMAB FOR OSTEOARTHRITIS PAIN: A 24-WEEK PHASE 3 STUDY WITH A 24-WEEK FOLLOW UP
Annals of the Rheumatic Diseases 2019;78:262-264.

Publication history

  • First published May 27, 2019.
Online issue publication 
May 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.